Anitrazafen is a specialty research chemical primarily studied for its potential applications in medical research, particularly as an anti-inflammatory agent. It has shown promise in treating eye conditions such as uveitis and other inflammatory disorders of the eye, as well as allergic reactions and skin conditions. Its mechanism of action involves inhibiting enzymes like lipoxygenase, which plays a key role in producing inflammatory mediators, thereby reducing swelling and discomfort. Available in 98% purity for laboratory use, it is not intended for clinical or human consumption. While not widely used in practice, ongoing studies continue to investigate its efficacy and safety.